Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study
A new study links Invokana, Farxiga and similar diabetes drugs to an increased risk of genital infections.
A new study links Invokana, Farxiga and similar diabetes drugs to an increased risk of genital infections.
A new study raises questions about FDA findings that Invokana and similar diabetes drugs can increase the risk of bone fractures.
The FDA is removing a black box warning from Invokana and similar drugs over the risk of leg and foot amputation, saying the risks are small, and that the drug…
A Farxiga lawsuit claims the manufacturers ignored scientific warning signs which should have pointed to the increased risk of flesh-eating groin infections.
A Farxiga lawsuit indicates the diabetes drug caused a flesh-eating infection that attacked a Texas man's genitals.
A Farxiga lawsuit claims the diabetes drug caused a man to suffer a flesh-eating infection of the groin.
A new study appears to confirm FDA warnings that Invokana and similar diabetes drugs increase the risk of diabetic ketoacidosis in type 2 diabetes patients.
Public Citizen has petitioned the FDA to add black box warnings to Invokana and similar drugs, contraindicating their use by Type 1 diabetics due to the risk of diabetic ketoacidosis.
A Xigduo lawsuit claims the combination diabetes drug's side effects caused a man to suffer a flesh-eating infection on his genitals.
An Invokana lawsuit claims the diabetes drug caused a man to develop a life-threatening, flesh eating infection which attacked his genitals.